ABI
SLXP

Adamant Biomedical Investments’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Adamant Biomedical Investments’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$5.17M Sell
45,000
-33,210
-42% -$4.02M 1.24% 27
2014
Q3 		$12.2M Buy
+78,210
New +$11.3M 3.05% 6

Other funds holding SLXP

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Adamant Biomedical Investments's SLXP Position: Q4 2014 in Review

Adamant Biomedical Investments reduced its SALIX PHARMACEUTICALS LTD DEL (SLXP) stake by 42% in Q4 2014, selling an estimated $4.02M and leaving 45,000 shares worth $5.17M. The position accounts for 1.24% of the portfolio, ranked #27.

Adamant Biomedical Investments first reported a position in SLXP in Q3 2014 and has held it in 2 quarters since. The position peaked at $12.2M in Q3 2014. 346 funds tracked by Wall St. Rank hold SLXP as of Q4 2014.

  • Adamant Biomedical Investments held 45,000 shares of SALIX PHARMACEUTICALS LTD DEL worth $5.17M as of Q4 2014.
  • Adamant Biomedical Investments sold 33,210 SALIX PHARMACEUTICALS LTD DEL shares in Q4 2014, an estimated $4.02M.
  • SALIX PHARMACEUTICALS LTD DEL made up 1.24% of Adamant Biomedical Investments's portfolio in Q4 2014, its #27 holding.
  • Adamant Biomedical Investments first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q3 2014 and has held it in 2 quarters since.
  • Adamant Biomedical Investments's SALIX PHARMACEUTICALS LTD DEL position peaked at $12.2M in Q3 2014.
  • 346 funds tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q4 2014.

Based on Adamant Biomedical Investments's 13F filing for Q4 2014, filed 13 Feb 2015.